Business
Publication of Circular and Notice of GM
Genedrive PLC announced that a circular regarding the completion of placing, further to the announcement on September 24, 2025, will be published on the company's website and posted to shareholders. The circular contains the notice convening the General Meeting to be held at 9:00 a.m. on October 15, 2025. Capitalized terms in the announcement shall bear the meanings given in the fundraising announcement made via RIS on September 23, 2025. Disclaimer*
About this update from Genedrive Plc
[{"type":"text","content":"\n\n29 September 2025\nTHIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR IN OR INTO ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW OR REGULATION.\n \nFURTHER, THIS ANNOUNCEMENT IS MADE FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER FOR SALE OR SUBSCRIPTION OF ANY SECURITIES IN THE COMPANY OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON SUBSCRIBE FOR OR OTHERWISE ACQUIRE SHARES IN GENEDRIVE PLC IN ANY JURISDICTION.\n \ngenedrive plc\n(\"genedrive\", the \"Group\" or the \"Company\")\n \nPublication of Circular and Notice of General Meeting\n \nManchester, UK - 29 September 2025: genedrive plc (LSE: GDR), the point of care pharmacogenetic testing company, announces that further to the announcement on 24 September 2025 confirming the completion of the Placing, a Circular will shortly be published on the Company's website, www.genedriveplc.com, and will be posted to Shareholders later today. The Circular contains the notice convening the General Meeting to be held at 9.00 a.m. on 15 October 2025.\n \nCapitalised terms in this announcement shall, unless the context demands otherwise, bear the meanings given to such terms in the announcement of the Fundraising made via RIS on 23 September 2025.\n \nEnquiries:\n \n\n\n\n\ngenedrive plc\n\n\n+44 (0) 161 989 0245\n\n\n\n\nDr Gino Miele (CEO)\nRuss Shaw (CFO)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPeel Hunt LLP - Nominated Adviser, Joint Broker and Joint Bookrunner\n\n\n +44 (0) 20 7148 8900\n\n\n\n\nJames Steel / Benjamin Harris (Investment Banking)\n\n\n \n\n\n\n\nSohail Akbar / Nicholas Wilks (ECM)\n\n\n \n\n\n\n\n \n\n\n \n\n\n\n\nAllenby Capital Limited - Joint Broker and Joint Bookrunner to the Placing\nNick Athanas / Vivek Bhardwaj (Corporate Finance)\nAmrit Nahal / Kelly Gardiner (Sales & Corporate Broking)\n \n\n\n \n\n\n\n\nWalbrook PR - Financial PR & IR Adviser\n\n\n+44 (0) 20 7933 8780\n\n\n\n\nAnna Dunph...